Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124966872 | 12496687 | 2 | F | 20160522 | 20160706 | 20160624 | 20160714 | EXP | GB-MHRA-ROCHE-1770793 | GB-FRESENIUS KABI-FK201603898 | FRESENIUS KABI | 46.00 | YR | M | Y | 70.60000 | KG | 20160714 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124966872 | 12496687 | 1 | PS | CISPLATIN (Manufacturer unknown) | CISPLATIN | 1 | Intravenous (not otherwise specified) | Y | U | 74735 | 80 | MG/M**2 | UNKNOWN | ||||||
| 124966872 | 12496687 | 2 | SS | CISPLATIN (Manufacturer unknown) | CISPLATIN | 1 | Intravenous (not otherwise specified) | Y | U | 74735 | 80 | MG/M**2 | UNKNOWN | ||||||
| 124966872 | 12496687 | 3 | SS | XELODA | CAPECITABINE | 1 | Oral | 0 | 1000 | MG/M**2 | |||||||||
| 124966872 | 12496687 | 4 | SS | XELODA | CAPECITABINE | 1 | Oral | 0 | 1450 | MG | BID | ||||||||
| 124966872 | 12496687 | 5 | C | COCODAMOL | ACETAMINOPHENCODEINE PHOSPHATE | 1 | 0 | ||||||||||||
| 124966872 | 12496687 | 6 | C | CYCLIZINE | CYCLIZINE | 1 | 0 | ||||||||||||
| 124966872 | 12496687 | 7 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 124966872 | 12496687 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 124966872 | 12496687 | 9 | C | MEGACE | MEGESTROL ACETATE | 1 | 0 | ||||||||||||
| 124966872 | 12496687 | 10 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 0 | ||||||||||||
| 124966872 | 12496687 | 11 | C | ONDANSETRON | ONDANSETRON | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124966872 | 12496687 | 1 | Oesophageal adenocarcinoma |
| 124966872 | 12496687 | 3 | Oesophageal adenocarcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124966872 | 12496687 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124966872 | 12496687 | Dehydration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124966872 | 12496687 | 1 | 20130415 | 20160506 | 0 | |
| 124966872 | 12496687 | 2 | 20160603 | 0 | ||
| 124966872 | 12496687 | 3 | 20130415 | 20160520 | 0 | |
| 124966872 | 12496687 | 4 | 20160603 | 0 |